메뉴 건너뛰기




Volumn 4, Issue 1, 2006, Pages 33-52

Treatment of acute leukaemias with monoclonal antibodies: Current status and future prospects

Author keywords

Alemtuzumab; ALL; AML; Gemtuzumab ozogamicin; Lymphoid antigens; Monoclonal antibodies; Myeloid antigens; Rituximab

Indexed keywords

ALEMTUZUMAB; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BISMUTH 213; CALICHEAMICIN GAMMA1; CD20 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD52 ANTIGEN; CELL RECEPTOR; CYCLOSPORIN A; CYTARABINE; EPRATUZUMAB; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; IDARUBICIN; IODINE 131; MITOXANTRONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LYM 1; MONOCLONAL ANTIBODY M 195; PSEUDOMONAS EXOTOXIN; RHENIUM 188; RICIN; RITUXIMAB; TOPOTECAN; TOSITUMOMAB I 131; UNINDEXED DRUG; YTTRIUM 90;

EID: 33646366431     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152506775268820     Document Type: Review
Times cited : (14)

References (166)
  • 8
    • 0034283695 scopus 로고    scopus 로고
    • Estey, E.H. Blood, 2000, 96, 1670.
    • (2000) Blood , vol.96 , pp. 1670
    • Estey, E.H.1
  • 22
    • 0001894976 scopus 로고
    • Broder, S.; Ed.; Williams and Wilkins: Baltimore
    • Schlom, J. In Molecular Foundations of Oncology; Broder, S.; Ed.; Williams and Wilkins: Baltimore, 1990, pp. 95.
    • (1990) Molecular Foundations of Oncology , pp. 95
    • Schlom, J.1
  • 25
    • 0036814890 scopus 로고    scopus 로고
    • Tallman, M.S. Sem. Hemat., 2002, 39 (4 Suppl. 3), 12.
    • (2002) Sem. Hemat. , vol.39 , Issue.4 SUPPL. 3 , pp. 12
    • Tallman, M.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.